D3-Vigantol | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

D3-Vigantol
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

D3-Vigantol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 19 USDMF, 15 CEP/COS, 2 JDMF, 6 EU WC, 5 NDC API, 22 Listed Suppliers, $ API Reference Price

54 API Suppliers
19 USDMF
15 CEP/COS
2 JDMF
6 EU WC
5 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

113 Drugs in Development

113 Drugs in Development

FINISHED DOSAGE FORMULATIONS

744 FDF Dossiers, 6 FDA Orange Book, 397 Europe, 38 Canada, 6 South Africa, 297 Listed Dossiers

744 FDF Dossiers
6 FDA Orange Book
397 Europe
38 Canada
6 South Africa
297 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
TABLET;ORAL - EQ 70MG BASE;2,800 IU
TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Rochem International Inc, 19 SPI Pharma, 18 DKSH, 2 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 14 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 32 BASF, 1 Bioplus Life Sciences, 5 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 11 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 54 Thickeners and Stabilizers, 53 Coating Systems & Additives, 40 Taste Masking, 38 Parenteral, 38 Solubilizers, 35 Direct Compression, 32 Granulation, 29 Topical, 28 Controlled & Modified Release, 24 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 21 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 17 Rheology Modifiers, 15 Co-Processed Excipients, 13 Emulsifying Agents, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

91 Fillers, Diluents & Binders
54 Thickeners and Stabilizers
53 Coating Systems & Additives
40 Taste Masking
38 Parenteral
38 Solubilizers
35 Direct Compression
32 Granulation
29 Topical
28 Controlled & Modified Release
24 Film Formers & Plasticizers
23 Disintegrants & Superdisintegrants
21 Chewable & Orodispersible Aids
18 Lubricants & Glidants
17 Rheology Modifiers
15 Co-Processed Excipients
13 Emulsifying Agents
9 Empty Capsules
8 Surfactant & Foaming Agents
8 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 25 News #PharmaBuzz

2 Data Compilation #PharmaFlow
25 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 361 Regulatory FDF Prices, 7 Annual Reports

1 US Medicaid Prescriptions
361 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

87 APIs, 23 FDF Dossiers

87 APIs
23 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 1 JP, 3 Others

3 EDQM
3 USP
1 JP
3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 661 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Merck Canada Inc.

filter Patent Reset all filters

5 All

01 22149052

02 12221417

03 22294595

filter Product Reset all filters

5 All

01 5Alendronate Sodium | Cholecalciferol

filter Dosage Reset all filters

5 All

01 3Tablet

02 2Tablets

filter Exp Date Reset all filters

5 All

01 22013-11-17

02 12016-06-03

03 22018-07-17

Product Main Page

01

Merck Canada Inc.

Alendronate Sodium, Vitamin D3

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-17

Date Granted : 2003-03-25

Alendronate Sodium, Vitamin D3

Brand Name : FOSAVANCE

Patent Number : 2149052

Filing Date : 1993-11-17

Strength per Unit : 70mg / 70mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-17

Date Granted : 2003-03-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Alendronate Sodium, Vitamin D3

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-03

Date Granted : 2002-04-30

Alendronate Sodium, Vitamin D3

Brand Name : FOSAVANCE

Patent Number : 2221417

Filing Date : 1996-06-03

Strength per Unit : 70mg / 70mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-03

Date Granted : 2002-04-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Alendronate Sodium, Vitamin D3

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Alendronate Sodium, Vitamin D3

Brand Name : FOSAVANCE

Patent Number : 2294595

Filing Date : 1998-07-17

Strength per Unit : 70mg / 70mcg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Alendronate Sodium, Vitamin D3

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-17

Date Granted : 2003-03-25

Alendronate Sodium, Vitamin D3

Brand Name : FOSAVANCE

Patent Number : 2149052

Filing Date : 1993-11-17

Strength per Unit : 70mg / 140 ug

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-17

Date Granted : 2003-03-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Merck Canada Inc.

Alendronate Sodium, Vitamin D3

CPhI Korea

Not Confirmed

Merck Canada Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Alendronate Sodium, Vitamin D3

Brand Name : FOSAVANCE

Patent Number : 2294595

Filing Date : 1998-07-17

Strength per Unit : 70mg / 140 ug

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-17

Date Granted : 2001-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!